Free Newsletter
Supplement's "enhancement" drives recall
Novacare is recalling all lots of a male sexual enhancement supplement distributed before mid-June. The recall follows the FDA's finding that the products--encompassing some 21 imaginatively named brands--"appear to contain sulfoaildenafil," which is undeclared on the labels. Sulfoaildenafil is a cousin to Sildenafil, more commonly known as Viagra. The products were distributed in bottles and blister cards to brick-and-mortar and online retailers. Recall notice
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: